Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma
Indapta Therapeutics, Inc. today announced the publication of new preclinical data in Blood Advances demonstrating the company’s proprietary…
Browsing Tag
Multiple Myeloma is a type of blood cancer. The reason it’s called multiple myeloma is that the individual has a malignant plasma cell that spreads into more than one location in the body. It can affect bone marrow and also cause other symptoms such as fever, infections, kidney problems, trouble urinating and lung problems.
Multiple Myeloma can be treated with a combination of therapies. The most common treatments are chemotherapy, radiation therapy and stem cell transplant. In some cases, surgery may also be used.
The prognosis for multiple myeloma varies depending on the stage of the disease when it is diagnosed. However, many people with multiple myeloma can live for several years with treatment.
There is currently no cure for multiple myeloma, but research is ongoing to find new treatments and improve the prognosis for people with this disease.
If you or someone you know has been diagnosed with multiple myeloma, please talk to your doctor about the best treatment options.